A heated constitutional and political battle is unfolding in Senegal as lawmakers examine whether Ousmane Sonko can reclaim his parliamentary seat after leaving government. The debate could reshape the balance of power inside the National Assembly.
An Ebola outbreak has spread accross the DRC and Uganda (Picture: AFP via Getty Images)
A 28-year-old woman who travelled to the Indian city of Bengaluru from Uganda has been placed in quarantine wit
SAN FRANCISCO,March 18,2025--Sensor Tower,a leading provider of digital marketing insights,announced today that it has acquired gaming intelligence platform Video Game Insights. This acquisition stre
FIFE,Scotland,March 18,2025-- MD Local Global Limited,a wholly owned subsidiary ofMDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"),an integrated global culture-driven asset manage
NEW YORK,March 18,2025--Bespin Global,an award-winning consulting firm specializing in financial services data & AI solutions for Google,Amazon,and Microsoft cloud platforms,today announced a str
HOUSTON,March 18,2025--The global sports fitness equipment brand DeerRun,recently announced the team\'s official deployment of a proprietary global logistics network platform. Utilizing AI real-time m
SAN JOSE,Calif.,March 19,2025-- MSI,a leading global provider of high-performance server solutions,showcased its cutting-edge 4U and 2U AI platforms built on the NVIDIA MGXreference architecture at GT
- After launching an exceptional airport journey at Paris-Charles de Gaulle in 2024,Air France is reinventing the travel experience on board its most exclusive cabin.
DALIAN,China,March 17,2025-- CBAK Energy Technology,Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company") a leading lithium-ion battery manufacturer and electric energy solution pr
NEW YORK,March 17,2025-- On March 28,2025,Tuya Smart (NYSE: TUYA,HKEX: 2391),a global AI cloud platform service provider,T3 Technology,and Skyworth,will take center stage to co-host the Global Telecom
HONG KONG,March 17,2025--Akeso Inc. (9926.HK) announced that its innovative,self-developed anti-PD-1 monoclonal antibody,penpulimab,has been officially approved by the National Medical Products Admini
